Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Equity Ratio: 2011-2019

Historic Equity Ratio for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to 0.24.

  • EyePoint Pharmaceuticals' Equity Ratio rose 48.57% to 0.24 in Q1 2019 from the same period last year, while for Mar 2019 it was 0.24, marking a year-over-year increase of 48.57%. This contributed to the annual value of 0.16 for FY2018, which is 77.16% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Equity Ratio stood at 0.24 for Q1 2019, which was down 49.56% from 0.48 recorded in Q4 2018.
  • EyePoint Pharmaceuticals' Equity Ratio's 5-year high stood at 0.78 during Q1 2015, with a 5-year trough of 0.16 in Q2 2018.
  • In the last 3 years, EyePoint Pharmaceuticals' Equity Ratio had a median value of 0.54 in 2018 and averaged 0.49.
  • In the last 5 years, EyePoint Pharmaceuticals' Equity Ratio tumbled by 77.16% in 2018 and then surged by 48.57% in 2019.
  • EyePoint Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.60 in 2015, then increased by 24.13% to 0.75 in 2016, then declined by 6.68% to 0.70 in 2017, then tumbled by 30.99% to 0.48 in 2018, then surged by 48.57% to 0.24 in 2019.
  • Its last three reported values are 0.24 in Q1 2019, 0.48 for Q4 2018, and 0.54 during Q3 2018.